Commercial plasma α1-antitrypsin (Prolastin®) contains a conformationally inactive, latent component

European Respiratory Journal

Volumn 10, Issue 3, 1997, Pages 672-675

  Lomas, D A ^a,b   Elliott, P R ^a,b   Carrell, R W ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

latent antitrypsin; pasteurisation; prolastin; serpins

Indexed keywords

ALPHA 1 ANTITRYPSIN; SERINE PROTEINASE INHIBITOR; CHYMOTRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANALYSIS; DRUG PURITY; DRUG RESEARCH; HUMAN; HUMAN TISSUE; LUNG EMPHYSEMA; PASTEURIZATION; PRIORITY JOURNAL; ANIMAL; CATTLE; CHEMISTRY; DRUG ANTAGONISM; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONFORMATION; WESTERN BLOTTING;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANIMALS; BLOTTING, WESTERN; CATTLE; CHYMOTRYPSIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; PHENOTYPE; PROTEIN CONFORMATION; PULMONARY EMPHYSEMA; SERINE PROTEINASE INHIBITORS;

EID: 0030615224     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 1-antitrypsin for structure and function of serpins. Biochemistry 1989; 28: 8951-8966 .
2. 1-antitrypsin PiZ. FEBS Lett 1976; 65: 195-197.
3. 1-antitrypsin causes a protein folding defect. Nature Struc Biol 1995; 2: 363-367.
4. 1-antitrypsin accumulation in the liver. Nature 1992; 357: 605-607.
5. 1-antitrypsin. Biochemistry 1993; 32: 500-508.
6. 52Phe deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerisation. J Biol Chem 1995; 270: 16864-16870.
7. 1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994; 91: 9014-9018.
8. 1-antitrypsin deficient children. Acta Paediatr Scand 1988; 77: 847-851.
9. 1-antitrypsin deficiency. N Eng J Med 1986; 314: 736-739.
10. 1-antitrypsin deficiency. Acta Med Scand 1965; Suppl. 432: 1-85.
11. 1-antitrypsin deficiency associated with emphysema. N Eng J Med 1987; 316: 1055-1062.
12. 1-antitrypsin. Nature Structural Biology 1996; 3: 676-681.
13. 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 1984; 177: 531-556.
14. Carrell RW, Stein PE, Fermi G, Wardell MR. Biological implications of a 3Å structure of dimeric antithrombin. Structure 1994; 2: 257-270.
15. 1-antitrypsin. J Biol Chem 1995; 270: 5282-5288.
16. Hekman CM, Loskutoff DJ. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 1985; 260: 11581-11587.
17. Levin EG, Santell L. Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells. Blood 1987; 70: 1090-1098.
18. Lawrence D, Strandberg L, Grundström T, Ny T. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli: comparison with natural and recombinant forms purified from eucaryotic cells. Eur J Biochem 1989; 186: 523-533.
19. 1-antitrypsin deficiency. Chest 1994; 106: 651-652.